GlassScriptPhysician profile
Robert T Lewis
NPI 1124175070
$3,946.75
in general payments reported to CMS, 2019-2025
18 companies · $2,702 in 2025
The $2,702 reported for 2025 was more than what 84% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $102 · 2021: $40.37 · 2022: $108 · 2023: $149 · 2024: $639 · 2025: $2,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,296 · Education: $1,000 · Food and Beverage: $794 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,296.40 |
| Education | $1,000.00 |
| Food and Beverage | $793.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,772.31 | 2019-2025 | |
| Janssen Biotech, INC. | $240.18 | 2023-2025 | Tremfya, Stelara, Simponi |
| Abbvie INC. | $224.75 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $139.04 | 2019-2023 | Entyvio, Gattex |
| Fujifilm Healthcare Americas Corporation | $119.40 | 2025 | |
| Covidien LP | $100.00 | 2019 | |
| Shire North American Group INC | $55.63 | 2019 | |
| Lilly USA, LLC | $51.55 | 2024-2025 | Omvoh |
| Thd America, INC. | $46.16 | 2020-2022 | |
| Celgene Corporation | $45.68 | 2022-2024 | Zeposia |
| Regeneron Healthcare Solutions, INC. | $27.38 | 2022 | |
| Ferring Pharmaceuticals INC. | $20.89 | 2022 | |
| Gilead Sciences, INC. | $19.68 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.66 | 2020 | |
| Medtronic, INC. | $17.82 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $17.69 | 2023 | Sutab |
| Masimo Corporation | $17.00 | 2021 | |
| Micro-Tech Endoscopy USA, INC. | $12.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.